Immunochina
Beijing
About Immunochina
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $45.2M
- Funding stage: Late Stage Venture
- Last round: Series E (Jan 2025)
- Website: immunochina.com
- Phone: 010-62886890
Industries & Categories
Biotechnology, Clinical Trials, Medical, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/immunochina-128147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.